<?xml version="1.0" encoding="UTF-8"?>
<p>Our data showed that ~70% of ICU-ARDS associated with IBV occurred in individuals &gt;64 years old, which was a similar situation to that in Italy as a whole [
 <xref rid="B22" ref-type="bibr">22</xref>]. The aTIV was recommended in Italy for the 2017-2018 season for this age group and provided free of charge [
 <xref rid="B4" ref-type="bibr">4</xref>]. Because of the impact of IBV in the elderly in the 2017-2018 influenza season, the Italian Ministry of Health has also recommended, for the 2018-2019 season, the use of QIV in individuals aged 65–74 years [
 <xref rid="B23" ref-type="bibr">23</xref>]. In Apulia region, for the elderly, the preferential use of QIV was recommended only for individuals in the 65–74-year age group who were at low risk (without multiple comorbidities) [
 <xref rid="B24" ref-type="bibr">24</xref>].
</p>
